Canadian Medical Association Journal article warns against relying on less effective treatments for anaphylaxis ...
Positive Regulatory Response Marks Important Milestone for NS002 Development ProgramTEL AVIV, Nov. 06, 2025 (GLOBE NEWSWIRE) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果